Stay updated with breaking news from Regulatory Strategy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Every recommendation contained in the final report of the capability review of the aged care regulatory body has been accepted by the federal government.
BRIDGEWATER, N.J.--(BUSINESS WIRE)--May 22, 2024--
Amneal Pharmaceuticals has initiated the distribution of OTC Naloxone HCI Nasal Spray to retail pharmacies across the US, including the State of California.
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that it has begun supplying its over-the-counter Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg to U.S. retail pharmacies and the State of California. The product...
Kraken considers delisting USDT due to upcoming regulatory changes in the European Union.